The 13th Annual Scientific Meeting of the Society for Neuro-Oncology
Lake Las Vegas, Nevada
1605 Lake Las Vegas Pkwy
Henderson, NV 89011 USA, NV

Schedule of Presentations:

Friday, November 21, 2008
08:00:00 WELCOME Michael A. Vogelbaum
08:15:00 Radiation Therapy (RT) Versus RT + Procarbazine, CCNU And Vincristine (PCV) Chemotherapy For Adult Low-Grade Glioma (LGG): Radiation Therapy Oncology Group (RTOG) Protocol 9802. Edward Shaw
08:30:00 Imatinib (I) Plus Hydroxyurea (HU) Versus Hydroxyurea Monotherapy In Progressive Glioblastoma (GBM) An International Multi-Center, Open Label, Randomised Phase III Study (Ambrosia-Study). Gregor Dresemann
08:45:00 Enzastaurin (ENZ) Versus Lomustine (CCNU) In The Treatment Of Recurrent, Intracranial Glioblastoma (GBM): A Phase III Study. Vinay K Puduvalli
09:00:00 Using Genetically-Engineered Mouse Models To Evaluate Novel Treatments For Pediatric Low-Grade Glioma. David Gutmann
09:15:00 Phase II Study Of Bevacizumab (BVZ) Plus Irinotecan (CPT-11) In Children With Recurrent Malignant Glioma (MG) And Diffuse Brain Stem Glioma (BSG) A Pediatric Brain Tumor Consortium Study (PBTC-022). Sridharan Gururangan
09:30:00 Primary Cilia Both Mediate And Suprress Sonic Hedgeghog-Dependent Medulloblastoma Formation. Young Goo Han
09:45:00 A Randomized Controlled Study Of The Immediate And Longer-Term Effects Of Cognitive Rehabilitation In Glioma Patients. Karin Gehring
10:00:00 BREAK
10:15:00 Cerebral Blood Volume Measurements By MR Imaging In Astrocytomas: Predicting Short-Term Outcome And Recurrent Disease Independently And As An Adjunct To Histopathology. Pierre Giglio
10:30:00 DSC-MRI Using Ferumoxytol May Help Differentiate Pseudoprogression From True Progression In Patients With Glioblastoma. A Preliminary Report. Edward Neuwelt
10:45:00 Parametric Response Mapping (PRM) Measured During Radiation Therapy For High-Grade Glioma Predicts Overall Survival. Daniel Hamstra
11:00:00 Imaging Glioblastoma Progression During Anti-VEGF Therapy. John de Groot
11:15:00 [18F]Galacto-RGD PET Allows Non-Invasive Detection Of V3 Integrin Expression In Malignant Gliomas. Oliver Schnell
11:30:00 Magnetic Resonance (MR) Tractography Of The Corticospinal Tract: Reduction But Not Deviation Correlates With Motor Deficit In Benign Extra-Cerebral Lesions. Cc Tchoyoson Lim
11:45:00 Response and Outcome Assessment in NeuroOncology: Update Susan Chang, Michael A. Vogelbaum, Patrick Y. Wen, David MacDonald, Martin Van Den Bent
12:00:00 LUNCH
13:00:00 Impact Of Extent Of Resection And Outcome To Adjuvant Chemotherapy. A Meta-Analysis Of Three EORTC Studies. Martin Van Den Bent
13:10:00 Outcome Of Children And Adults With Recurrent Central Nervous System (CNS) Germ Cell Tumors (GCT): A Retrospective Study, 2003 2008. Jonathan Finlay
13:20:00 The Temozolomide Rescue Study: A Phase II Trial Of Continuous (28/28) Dose-Intense Temozolomide (TMZ) After Progression On Conventional 5/28 Day TMZ In Patients With Recurrent Malignant Glioma. Warren P. Mason
13:30:00 Phase I/II Study Of Erlotinib And Temsirolimus (CCI-779) For Patients With Recurrent Malignant Gliomas (NABTC 04-02). Patrick Y. Wen
13:40:00 Is Response A Meaningful Surrogate For Survival Endpoints In Clinical Trials Involving Newly Diagnosed And Recurrent Glioblastoma Patients ? A North Central Cancer Treatment Group (NCCTG) Study. Kurt Jaeckle
13:50:00 Treatment Of Operable High-Grade Glioma With Sitimagene Ceradenovec (Cerepro) Gene Therapy And Ganciclovir; Results Of A Phase III, Randomized Trial Of 250 Patients. Zvi Ram
14:00:00 Impact Of Intraoperative High-Field Magnetic Resonance Imaging On Volumetric Extent Of Resection In Glioma Patients. Mustafa Aziz Hatiboglu
14:10:00 Bevacizumab Salvage Therapy Following Progression In High-Grade Glioma Patients Treated With VEGF Receptor Tyrosine Kinase Inhibitors.
14:30:00 Role Of A Second Chemotherapy In Recurrent Malignant Glioma In Patients Who Progress On A Bevacizumab-Containing Regimen. Eudocia C Quant
14:40:00 Integration Of Metabolic Imaging And Molecular Genetic Profiling Of Serial Stereotactic Biopsies Are Valuable For Histological Discrimination Of Oligodendrogliomas, Mixed Oligoastrocytomas And Astrocytomas WHO II/III. Niklas Thon
14:50:00 Intensive Resection Of The Pseudocapsule Of Pituitary Adenoma: Long-Term Results Jung Yong Ahn
15:00:00 BREAK
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.